Current concepts in periodontal diseases;Maladies parodontales: Connaissances actuelles

Medecine et Maladies Infectieuses

Volumn 33, Issue 7, 2003, Pages 331-340

  Houle, M A ^a   Grenier, D ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

Antibiotics; Cytokines; Periodontal diseases; Virulence

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; CYTOKINE; GELATINASE A; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; PROSTAGLANDIN E2; STROMELYSIN; TUMOR NECROSIS FACTOR ALPHA;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; MOUTH HYGIENE; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; REVIEW; TANNERELLA FORSYTHENSIS; TISSUE INJURY; TREATMENT INDICATION; VIRUS CULTURE; VIRUS INFECTIVITY; VIRUS PATHOGENESIS;

EID: 0038163806     PISSN: 0399077X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-077X(03)00203-8     Document Type: Review

References (81)

1. Wilson TG, Kornman KS. The periodontium in health and disease. In: Wilson TG, Kornman KS, editors. Fundamentals of periodontitis. Carol Stream: Quintessence Books; 1996. p. 281-3.
2. The American Academy of Periodontology. Diagnosis of periodontal diseases. Committee on Research, Sciences and Therapy. Chicago: The American Academy of Periodontology; Avril 1995.
3. The American Academy of Periodontology. Proceedings of the World Workshop in Clinical Periodontics. Chicago: The American Academy of Periodontology; 1989. p. 1/23-4.
4. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
5. Goodson JM, Tanner AC, Haffajee AD, Sornberger GC, Socransky SS. Patterns of progression and regression of advanced destructive periodontal disease. J Clin Periodontol 1982;9:472-81.
6. Lindhe J, Haffajee AD, Socransky SS. Progression of periodontal disease in adult subjects in the absence of periodontal therapy. J Clin Periodontol 1983;10:433-42.
7. Socransky SS, Haffajee AD, Goodson JM, Lindhe J. New concepts of destructive periodontal disease. J Clin Periodontol 1984;11:21-32.
8. Jeffcoat MK, Reddy MS. Progression of probing attachment loss in adult periodontitis. J Periodontol 1991;62:185-9.
9. Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical periodontal therapy. V. Patterns of probing attachment loss in non-responding sites. J Clin Periodontol 1985;12:270-82.
10. Lemaitre P, Bassede C. Intérêt de l'étude de la microflore parodontale en microscopie directe: Le point 10 ans après Listgarten et Hellden. J Parodontol 1988;7:397-407.
11. Cohen L, Rams T, Slots J, Walker C. Independent analyses of microbiological samples by three testing laboratories. J Dent Res 2001;80: 219.
12. Loesche WJ, Lopatin DE, Stoll J, van Poperin N, Hujoel P. Comparison of various detection methods for periodontopathic bacteria: can culture be considered the primary reference standard? J Clin Microbiol 1992;30:418-26.
13. Tanner AC, Maiden MF, Zambon JJ, Thoren GS, Kent RL. Rapid chair-side DNA probe assay of Bacteroides forsythus and Porphyromonas gingivalis. J Periodontal Res 1998;33:105-17.
14. Conrads G. DNA probes and primers in dental practice. Clin Infect Dis 2002;35:S72-7.
15. Persson GR, Page RC. Diagnostic characteristics of crevicular fluid aspartate aminotransferase (AST) levels associated with periodontal disease activity. J Clin Periodontol 1992;19:43-8.
16. Loesche WJ, Bretz WA, Kerschensteiner D, Stoll J, Socransky SS, Hujoel P, et al. Development of a diagnostic test for anaerobic periodontal infections based on plaque hydrolysis of benzoyl-DL-arginine-naphthylamide. J Clin Microbiol 1990;28:1551-9.
17. Eley BM, Cox SW. Advances in periodontal diagnosis. 7. Proteolytic and hydrolytic enzymes link with periodontitis. Brit Dent J 1998;184: 323-8.
18. Loe H, Anerud A, Boysen H, Morrison E. Natural history of periodontal disease in man. Rapid, moderate and no loss of attachment in Sri Lankan laborers 14 to 46 years of age. J Clin Periodontol 1986; 13: 431-45.
19. Position paper: epidemiology of periodontal diseases. American Academy of Periodontology. J Periodontol 1996;67:935-45.
20. Papapanou PN. Epidemiology of periodontal diseases: an update. Int Acad Periodontol 1999;4:110-6.
21. Stoltenberg JL, Osborn JB, Pihlstrom BL, Herzberg MC, Aeppli DM, Wolff LF, et al. Association between cigarette smoking, bacterial pathogens, and periodontal status. J Periodontol 1993;64:1225-30.
22. Haffajee AD, Socransky SS, Smith C, Dibart S. Relation of baseline microbial parameters to future periodontal attachment loss. J Clin Periodontol 1991;18:744-50.
23. The American Academy of Periodontology. The pathogenesis of periodontal diseases. J Periodontol 1999;70:457-70.
24. Wolff L, Dahlen G, Aeppli D. Bacteria as risk markers for periodontitis. J Periodontol 1994;65:498-510.
25. Pabst MJ, Pabst KM, Collier JA, Coleman TC, Lemons-Prince ML, Godat MS, Waring MB, Babu JP. Inhibition of neutrophil and monocyte defensive functions by nicotine. J Periodontol 1995;66:1047-55.
26. Sayers NM, Gomes BP, Drucker DB, Blinkhorn AS. Possible lethal enhancement of toxins from putative periodontopathogens by nicotine: implications for periodontal disease. J Clin Pathol 1997;50: 245-9.
27. Kornman KS, Crane A, Wang HY, di Giovine FS, Newman MG, Pirk FW, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997;24:72-7.
28. Kornman KS, di Giovine FS. Genetic variations in cytokine expression: a risk factor for severity of adult periodontitis. Ann Periodontol 1998;3:327-38.
29. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 1997;14:216-48.
30. Gendron R, Grenier D, Maheu-Robert L. The oral cavity as a reservoir of bacterial pathogens for focal infections. Microbes Infect 2000;2: 897-906.
31. Paquette DW. The periodontal infection-systemic disease link: a review of the truth or myth. J Int Acad Periodontol 2002;4:102-9.
32. Löe H, Theilade E, Jensen SB. Experimental gingivitis in man. II. A longitudinal clinical and bacteriological investigation. J Periodontal Res 1966;1:1-13.
33. Theilade E. The non-specific theory in microbial etiology of inflammatory periodontal diseases. J Clin Periodontol 1986;13:905-11.
34. Slots J. Microflora in the healthy gingival sulcus in man. Scand J Dent Res 1977;85:247-54.
35. Moore WE, Moore LV. The bacteria of periodontal diseases. Periodontol 2000 1994;5:66-77.
36. Haffajee AD, Socransky SS. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994;5:78-111.
37. Slots J, Listgarten MA. Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in human periodontal diseases. J Clin Periodontol 1988; 15:85-93.
38. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25: 134-44.
39. Asikainen S, Chen C. Oral ecology and person-to-person transmission of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Periodontol 2000 1999;20:65-81.
40. Savitt ED, Kent RL. Distribution of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis by subject age. J Periodontol 1991;62:490-4.
41. Loos BG, Van Winkelhoff AJ, Dunford RG, Genco RJ, De Graaff J, Dickinson DP, et al. A statistical approach to the ecology of Porphyromonas gingivalis. J Dent Res 1992;71:353-8.
42. Madianos PN, Papapanou PN, Socransky SS, Dahlen G, Sandros J. Host-related genotypic heterogeneity of Porphyromonas gingivalis strains in the beagle dog. Oral Microbiol Immunol 1994;9:241-7.
43. Saarela M, von Troil-Linden B, Torkko H, Stucki AM, Alaluusua S, Jousimies-Somer H, et al. Transmission of oral bacterial species between spouses. Oral Microbiol Immunol 1993;8:349-54.
44. Lamont RJ, Jenkinson HF. Adhesion as an ecological determinant in the oral cavity. In: Kuramitsu HK, Ellen RP, editors. Oral bacterial ecology, the molecular basis. Wymondham: Horizon Scientific Press; 2000. p. 131-68.
45. Labbé S, Leke N, Marcotte C, Vayssier C, Duchesne P, Mayrand D, et al. Interactions bactériennes: rôle déterminant lors des parodontites. Med Mal Infect 1998;28:186-92.
46. Gilbert P, Das J, Foley I. Biofilm susceptibility to antimicrobials. Adv Dent Res 1997;11:160-7.
47. Shah HN, Gharbia SE. Batch culture and physiological properties. In: Shah HN, Mayrand D, Genco RJ, editors. Biology of the species Porphyromonas gingivalis. Boca Raton: CRC Press; 1993. p. 85-103.
48. Gharbia SE, Shah HN, Welch SG. The influence of peptides on the uptake of amino acids in Fusobacterium: predicted interaction with Porphyromonnas gingivalis. Curr Microbiol 1989;19:231-5.
49. Grenier D, Mayrand D. Periodontitis as an ecological imbalance. In: Kuramitsu HK, Ellen RP, editors. Oral bacterial ecology, the molecular basis. Wymondham: Horizon Scientific Press; 2000. p. 275-310.
50. Holt SC, Kesavalu L, Walker S, Genco CA. Virulence factors of Porphyromonas gingivalis. Periodontol 2000 1999;20:168-238.
51. Potempa J, Banbula A, Travis J. Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000 2000; 24:153-92.
52. Lamont RJ, Yilmaz O. In or out: the invasiveness of oral bacteria. Periodontol 2000 2002;30:61-9.
53. Ding Y, Uitto VJ, Firth J, Salo T, Haapasalo M, Konttinen YT, et al. Modulation of host matrix metalloproteinases by bacterial virulence factors relevant in human periodontal diseases. Oral Dis 1995;1: 279-86.
54. Stevens RH, Hammond BF. The comparative cytotoxicity of periodontal bacteria. J Periodontol 1988;59:741-9.
55. Johansson A, Bergenholtz A, Holm SE. Cytotoxicity in bacterial cultures: interaction and cell-specificity, possible factors in periodontal disease. J Periodontal Res 1994;29:318-23.
56. Contreras A, Slots J. Mammalian viruses in human periodontitis. Oral Microbiol Immunol 1996;11:381-6.
57. Contreras A, Umeda M, Chen C, Bakker I, Morrison JL, Slots J. Relationship between herpesviruses and adult periodontitis and periodontopathic bacteria. J Periodontol 1999;70:478-84.
58. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 1997;14:33-53.
59. Kinane DF, Lappin DF. Clinical, pathological and immunological aspects of periodontal disease. Odontol Scand 2001;59:154-60.
60. Okada H, Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 1998;9:248-66.
61. Offenbacher S, Salvi GE. Induction of prostaglandin release from macrophages by bacterial endotoxin. Clin Infect Dis 1999;28:505-13.
62. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
63. Ryan ME, Golub LM. Modulation of matrix metalloproteinase activities in periodontitis as a treatment strategy. Periodontol 2000 2000;24: 226-38.
64. The American Academy of Periodontology. Host Modulation in Management of Periodontal Diseases. Chicago: The American Academy of Periodontology; Avril 1990.
65. Feldman RS, Szeto B, Chauncey HH, Goldhaber P. Non-steroidal anti-inflammatory drugs in the reduction of human alveolar bone loss. J Clin Periodontol 1983:10:131-6.
66. Williams RC, Jeffcoat MK, Howell TH, Rolla A, Stubbs D, Teoh KW, et al. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 1989;60:485-90.
67. Howell TH, Jeffcoat MK, Goldhaber P, Reddy MS, Kaplan ML, Johnson HG, et al. Inhibition of alveolar bone loss in beagles with the NSAID naproxen. J Periodontal Res 1991;26:498-501.
68. The American Academy of Periodontology. Guidelines for periodontal therapy. The American Academy of Periodontology. J Periodontol 1998;69:405-8.
69. Soskolne WA, Chajek T, Flashner M, Landau I, Stabholtz A, Kolatch B, et al. An in vivo study of the chlorhexidine release profile of the PerioChip in the gingival crevicular fluid, plasma and urine. J Clin Periodontol 1998;25:1017-21.
70. Stoller NH, Johnson LR, Trapnell S, Harrold CQ, Garrett S. The pharmacokinetic profile of a biodegradable controlled-release delivery system containing doxycycline compared to systemically delivered doxycycline in gingival crevicular fluid, saliva, and serum. J Periodontol 1998;69:1085-91.
71. Stoltze K. Elimination of Elyzol 25% Dentalgel matrix from periodontal pockets. J Clin Periodontol 1995;22:185-7.
72. Higashi K, Matsushita M, Morisaki K, Hayashi S, Mayumi T. Local drug delivery systems for the treatment of periodontal disease. J Pharmacobiodyn 1991;14:72-81.
73. Ainamo J, Lie T, Ellingsen BH, Hansen BF, Johansson LA, Karring T, et al. Clinical responses to subgingival application of a metronidazole 25% gel compared to the effect of subgingival scaling in adult periodontitis. J Clin Periodontol 1992;19:723-9.
74. Drisko CL, Cobb CM, Killoy WJ, Michalowicz BS, Pihlstrom BL, Lowenguth RA, et al. Evaluation of periodontal treatments using controlled-release tetracycline fibers: clinical response. J Periodontol 1995;66:692-9.
75. Garrett S, Johnson L, Drisko CH, Adams DF, Bandt C, Beiswanger B, et al. Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis. J Periodontol 1999;70:490-503.
76. The American Academy of Periodontology. Systemic antibiotics in periodontics. J Periodontol 1996;67:831-8.
77. Seymour RA, Heasman PA. Tetracyclines in the management of periodontal diseases. A review. J Clin Periodontol 1995;22:22-35.
78. Roose JP, Van Noorden CJ. Synthetic protease inhibitors: promising compounds to arrest pathobiologic processes. J Lab Clin Med 1995; 125:433-41.
79. Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, et al. Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodontal Res 1983;18:516-26.
80. Golub LM, Wolff M, Lee HM, McNamara TF, Ramamurthy NS, Zambon J, et al. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodontal Res 1985;20:12-23.
81. Golub LM, Suomalainen K, Sorsa T. Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dent 1992;2:80-90.